Effects of Short Term, High Dose Atorvastatin Therapy on Periprocedural Myonecrosis and Platelet Inhibition After Percutaneous Coronary Intervention (PCI)

NCT00979940 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

60

Enrollment

OTHER

Sponsor class

Stopped Slower than anticipated enrollment for pilot study.

Conditions

Coronary Artery Disease

Interventions

DRUG: Atorvastatin

Sponsor

Indiana University

Collaborators

[object Object]